Questões de Vestibular CESMAC 2016 para Prova Medicina-2017.1- 1° DIA- PROVA TIPO 1
Foram encontradas 8 questões
Ano: 2016
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2016 - CESMAC - Prova Medicina-2017.1- 1° DIA- PROVA TIPO 1 |
Q1331712
Inglês
Texto associado
The material was designed to be embedded with medicallyuseful electronics, such as conductive wires, semiconductor chips, LED lights, and temperature sensors, according to a study published online December 7, 2015 in the journal Advanced Materials.
Electronics coated in the hydrogel could be placed not only on the surface of the skin but also inside the body—such as implanted biocompatible glucose sensors or soft, compliant neural probes, the researchers wrote.
“Electronics are usually hard and dry, but the human body is soft and wet. These two systems have drastically different properties,” said lead investigator Xuanhe Zhao, Associate Professor in MIT’s Department of Mechanical Engineering.
Dr. Zhao explained, “If you want to put electronics in close contact with the human body for applications such as health care monitoring and drug delivery, it is highly desirable to make the electronic devices soft and stretchable to fit the environment of the human body. That’s the motivation for stretchable hydrogel electronics.”
Current hydrogels are often brittle and made of degradable biomaterials that don’t last long, he explained. So, his team designed a hydrogel that is not only as flexible as human soft tissues, but can bond strongly to non-porous surfaces such as gold, titanium, aluminum, silicon, glass, and ceramic.
Read the text below and answer the following question based on it.
Stretchable hydrogel can be used as a 'smart bandage' and delivery vehicle for medical devices.
Engineers at MIT have developed an elastic yet sturdy hydrogel material that can be used as flexible, biocompatible wound dressing and as a smart delivery method for drugs or medical devices.The material was designed to be embedded with medicallyuseful electronics, such as conductive wires, semiconductor chips, LED lights, and temperature sensors, according to a study published online December 7, 2015 in the journal Advanced Materials.
Electronics coated in the hydrogel could be placed not only on the surface of the skin but also inside the body—such as implanted biocompatible glucose sensors or soft, compliant neural probes, the researchers wrote.
“Electronics are usually hard and dry, but the human body is soft and wet. These two systems have drastically different properties,” said lead investigator Xuanhe Zhao, Associate Professor in MIT’s Department of Mechanical Engineering.
Dr. Zhao explained, “If you want to put electronics in close contact with the human body for applications such as health care monitoring and drug delivery, it is highly desirable to make the electronic devices soft and stretchable to fit the environment of the human body. That’s the motivation for stretchable hydrogel electronics.”
Current hydrogels are often brittle and made of degradable biomaterials that don’t last long, he explained. So, his team designed a hydrogel that is not only as flexible as human soft tissues, but can bond strongly to non-porous surfaces such as gold, titanium, aluminum, silicon, glass, and ceramic.
Adaptado de: <http://www.mdlinx.com/medicalstudent/article/395#> Acessado em 15 de setembro de 2016.
The hydrogel material which engineers have come up
with at MIT
Ano: 2016
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2016 - CESMAC - Prova Medicina-2017.1- 1° DIA- PROVA TIPO 1 |
Q1331713
Inglês
Texto associado
The material was designed to be embedded with medicallyuseful electronics, such as conductive wires, semiconductor chips, LED lights, and temperature sensors, according to a study published online December 7, 2015 in the journal Advanced Materials.
Electronics coated in the hydrogel could be placed not only on the surface of the skin but also inside the body—such as implanted biocompatible glucose sensors or soft, compliant neural probes, the researchers wrote.
“Electronics are usually hard and dry, but the human body is soft and wet. These two systems have drastically different properties,” said lead investigator Xuanhe Zhao, Associate Professor in MIT’s Department of Mechanical Engineering.
Dr. Zhao explained, “If you want to put electronics in close contact with the human body for applications such as health care monitoring and drug delivery, it is highly desirable to make the electronic devices soft and stretchable to fit the environment of the human body. That’s the motivation for stretchable hydrogel electronics.”
Current hydrogels are often brittle and made of degradable biomaterials that don’t last long, he explained. So, his team designed a hydrogel that is not only as flexible as human soft tissues, but can bond strongly to non-porous surfaces such as gold, titanium, aluminum, silicon, glass, and ceramic.
Read the text below and answer the following question based on it.
Stretchable hydrogel can be used as a 'smart bandage' and delivery vehicle for medical devices.
Engineers at MIT have developed an elastic yet sturdy hydrogel material that can be used as flexible, biocompatible wound dressing and as a smart delivery method for drugs or medical devices.The material was designed to be embedded with medicallyuseful electronics, such as conductive wires, semiconductor chips, LED lights, and temperature sensors, according to a study published online December 7, 2015 in the journal Advanced Materials.
Electronics coated in the hydrogel could be placed not only on the surface of the skin but also inside the body—such as implanted biocompatible glucose sensors or soft, compliant neural probes, the researchers wrote.
“Electronics are usually hard and dry, but the human body is soft and wet. These two systems have drastically different properties,” said lead investigator Xuanhe Zhao, Associate Professor in MIT’s Department of Mechanical Engineering.
Dr. Zhao explained, “If you want to put electronics in close contact with the human body for applications such as health care monitoring and drug delivery, it is highly desirable to make the electronic devices soft and stretchable to fit the environment of the human body. That’s the motivation for stretchable hydrogel electronics.”
Current hydrogels are often brittle and made of degradable biomaterials that don’t last long, he explained. So, his team designed a hydrogel that is not only as flexible as human soft tissues, but can bond strongly to non-porous surfaces such as gold, titanium, aluminum, silicon, glass, and ceramic.
Adaptado de: <http://www.mdlinx.com/medicalstudent/article/395#> Acessado em 15 de setembro de 2016.
It is true to affirm that
Ano: 2016
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2016 - CESMAC - Prova Medicina-2017.1- 1° DIA- PROVA TIPO 1 |
Q1331714
Inglês
Texto associado
Chronic loneliness is as bad for our health as smoking 15 cigarettes a day and as damaging as obesity and physical inactivity. It is linked with depression, dementia and high blood pressure alongside a number of other conditions. Loneliness impacts on our struggling health and social care system, with evidence showing that those living with loneliness are far more likely to visit their local doctor or A&E. New research shows the health cost alone of loneliness is equivalent to some £12,000 per person over 15 years.
National and local policymakers are now waking up. Health and wellbeing boards across England are making loneliness a priority and the Welsh and Scottish governments have recently announced commitments to develop national cross-governmental strategies to address loneliness and social isolation.
We are calling on the UK government to follow suit and commit to the development of a UK-wide strategy for tackling loneliness and social isolation to help end this growing crisis.
Read the text below and answer the following
question based on it.
Treating the UK’s loneliness epidemic
Over a million people in the UK aged over 65 now
experience chronic loneliness. This figure will only rise as
our population ages. And research shows that severe
loneliness affects people across their life course, including
children and young people.Chronic loneliness is as bad for our health as smoking 15 cigarettes a day and as damaging as obesity and physical inactivity. It is linked with depression, dementia and high blood pressure alongside a number of other conditions. Loneliness impacts on our struggling health and social care system, with evidence showing that those living with loneliness are far more likely to visit their local doctor or A&E. New research shows the health cost alone of loneliness is equivalent to some £12,000 per person over 15 years.
National and local policymakers are now waking up. Health and wellbeing boards across England are making loneliness a priority and the Welsh and Scottish governments have recently announced commitments to develop national cross-governmental strategies to address loneliness and social isolation.
We are calling on the UK government to follow suit and commit to the development of a UK-wide strategy for tackling loneliness and social isolation to help end this growing crisis.
Adaptado de: <https://www.theguardian.com/society/2016/oct/04/treating-ukloneliness-epidemic> Acessado em 4 de outubro de 2016.
Chronic loneliness
Ano: 2016
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2016 - CESMAC - Prova Medicina-2017.1- 1° DIA- PROVA TIPO 1 |
Q1331715
Inglês
Texto associado
Chronic loneliness is as bad for our health as smoking 15 cigarettes a day and as damaging as obesity and physical inactivity. It is linked with depression, dementia and high blood pressure alongside a number of other conditions. Loneliness impacts on our struggling health and social care system, with evidence showing that those living with loneliness are far more likely to visit their local doctor or A&E. New research shows the health cost alone of loneliness is equivalent to some £12,000 per person over 15 years.
National and local policymakers are now waking up. Health and wellbeing boards across England are making loneliness a priority and the Welsh and Scottish governments have recently announced commitments to develop national cross-governmental strategies to address loneliness and social isolation.
We are calling on the UK government to follow suit and commit to the development of a UK-wide strategy for tackling loneliness and social isolation to help end this growing crisis.
Read the text below and answer the following
question based on it.
Treating the UK’s loneliness epidemic
Over a million people in the UK aged over 65 now
experience chronic loneliness. This figure will only rise as
our population ages. And research shows that severe
loneliness affects people across their life course, including
children and young people.Chronic loneliness is as bad for our health as smoking 15 cigarettes a day and as damaging as obesity and physical inactivity. It is linked with depression, dementia and high blood pressure alongside a number of other conditions. Loneliness impacts on our struggling health and social care system, with evidence showing that those living with loneliness are far more likely to visit their local doctor or A&E. New research shows the health cost alone of loneliness is equivalent to some £12,000 per person over 15 years.
National and local policymakers are now waking up. Health and wellbeing boards across England are making loneliness a priority and the Welsh and Scottish governments have recently announced commitments to develop national cross-governmental strategies to address loneliness and social isolation.
We are calling on the UK government to follow suit and commit to the development of a UK-wide strategy for tackling loneliness and social isolation to help end this growing crisis.
Adaptado de: <https://www.theguardian.com/society/2016/oct/04/treating-ukloneliness-epidemic> Acessado em 4 de outubro de 2016.
The UK authorities
Ano: 2016
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2016 - CESMAC - Prova Medicina-2017.1- 1° DIA- PROVA TIPO 1 |
Q1331716
Inglês
Texto associado
Read the text below and answer the following
question based on it.
Women taking pill more likely to be
treated for depression, study finds
Millions of women worldwide use hormonal contraceptives,
and there have long been reports that they can affect mood.
A research project was launched in Denmark to look at the
scale of the problem, involving the medical records of more
than a million women and adolescent girls.
It found that those on the combined pill were 23% more
likely to be prescribed an antidepressant by their doctor,
most commonly in the first six months after starting on the
pill. Women on the progestin-only pills, a synthetic form of
the hormone progesterone, were 34% more likely to take
antidepressants or get a first diagnosis of depression than
those not on hormonal contraception.
The study found that not only women taking pills but also
those with implants, patches and intrauterine devices were
affected.
Adolescent girls appeared to be at highest risk. Those
taking combined pills were 80% more likely and those on
progestin-only pills more than twice as likely to be
prescribed an antidepressant than their peers who were not
on the pill.
The researchers, Øjvind Lidegaard of the University of
Copenhagen and colleagues, point out that women are
twice as likely to suffer from depression in their lifetime as
men, though rates are equal before puberty. The fluctuating
levels of the two female sex hormones, oestrogen and
progesterone, have been implicated. Studies have
suggested raised progesterone levels in particular may
lower mood.
The impact of low-dose hormonal contraception on mood
and possibly depression has not been fully studied, the
authors say. They used registry data in Denmark on more
than a million women and adolescent girls aged between 15
and 34. They were followed up from 2000 until 2013 with an
average follow-up of 6.4 years.
The authors call for more studies to investigate this possible
side-effect of the pill.
Adaptado de: <
https://www.theguardian.com/society/2016/sep/28/women-takingcontraceptive-pill-more-likely-to-be-treated-for-depression-studyfinds> Acessado em 29 de setembro de 2016.
Hormonal contraceptives
Ano: 2016
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2016 - CESMAC - Prova Medicina-2017.1- 1° DIA- PROVA TIPO 1 |
Q1331717
Inglês
Texto associado
Read the text below and answer the following
question based on it.
Women taking pill more likely to be
treated for depression, study finds
Millions of women worldwide use hormonal contraceptives,
and there have long been reports that they can affect mood.
A research project was launched in Denmark to look at the
scale of the problem, involving the medical records of more
than a million women and adolescent girls.
It found that those on the combined pill were 23% more
likely to be prescribed an antidepressant by their doctor,
most commonly in the first six months after starting on the
pill. Women on the progestin-only pills, a synthetic form of
the hormone progesterone, were 34% more likely to take
antidepressants or get a first diagnosis of depression than
those not on hormonal contraception.
The study found that not only women taking pills but also
those with implants, patches and intrauterine devices were
affected.
Adolescent girls appeared to be at highest risk. Those
taking combined pills were 80% more likely and those on
progestin-only pills more than twice as likely to be
prescribed an antidepressant than their peers who were not
on the pill.
The researchers, Øjvind Lidegaard of the University of
Copenhagen and colleagues, point out that women are
twice as likely to suffer from depression in their lifetime as
men, though rates are equal before puberty. The fluctuating
levels of the two female sex hormones, oestrogen and
progesterone, have been implicated. Studies have
suggested raised progesterone levels in particular may
lower mood.
The impact of low-dose hormonal contraception on mood
and possibly depression has not been fully studied, the
authors say. They used registry data in Denmark on more
than a million women and adolescent girls aged between 15
and 34. They were followed up from 2000 until 2013 with an
average follow-up of 6.4 years.
The authors call for more studies to investigate this possible
side-effect of the pill.
Adaptado de: <
https://www.theguardian.com/society/2016/sep/28/women-takingcontraceptive-pill-more-likely-to-be-treated-for-depression-studyfinds> Acessado em 29 de setembro de 2016.
As for the dangers of contraceptives, teenagers
Ano: 2016
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2016 - CESMAC - Prova Medicina-2017.1- 1° DIA- PROVA TIPO 1 |
Q1331718
Inglês
Texto associado
Read the text below and answer the following
question based on it.
Women taking pill more likely to be
treated for depression, study finds
Millions of women worldwide use hormonal contraceptives,
and there have long been reports that they can affect mood.
A research project was launched in Denmark to look at the
scale of the problem, involving the medical records of more
than a million women and adolescent girls.
It found that those on the combined pill were 23% more
likely to be prescribed an antidepressant by their doctor,
most commonly in the first six months after starting on the
pill. Women on the progestin-only pills, a synthetic form of
the hormone progesterone, were 34% more likely to take
antidepressants or get a first diagnosis of depression than
those not on hormonal contraception.
The study found that not only women taking pills but also
those with implants, patches and intrauterine devices were
affected.
Adolescent girls appeared to be at highest risk. Those
taking combined pills were 80% more likely and those on
progestin-only pills more than twice as likely to be
prescribed an antidepressant than their peers who were not
on the pill.
The researchers, Øjvind Lidegaard of the University of
Copenhagen and colleagues, point out that women are
twice as likely to suffer from depression in their lifetime as
men, though rates are equal before puberty. The fluctuating
levels of the two female sex hormones, oestrogen and
progesterone, have been implicated. Studies have
suggested raised progesterone levels in particular may
lower mood.
The impact of low-dose hormonal contraception on mood
and possibly depression has not been fully studied, the
authors say. They used registry data in Denmark on more
than a million women and adolescent girls aged between 15
and 34. They were followed up from 2000 until 2013 with an
average follow-up of 6.4 years.
The authors call for more studies to investigate this possible
side-effect of the pill.
Adaptado de: <
https://www.theguardian.com/society/2016/sep/28/women-takingcontraceptive-pill-more-likely-to-be-treated-for-depression-studyfinds> Acessado em 29 de setembro de 2016.
The impact of low-dose hormonal contraception on
mood and possibly depression
Ano: 2016
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2016 - CESMAC - Prova Medicina-2017.1- 1° DIA- PROVA TIPO 1 |
Q1331719
Inglês
Texto associado
Read the comic strip below and answer the following
question based on it.
Disponível em: <https://br.pinterest.com/pin/287386019951245629/> Acessado em 15 de setembro de 2016.
The message above suggests that
Conheça nossos planos